1-7 of 7
maytansine
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Trph-222, a Novel Anti-CD22 Antibody Drug Conjugate (ADC), Has Signficant Anti-Tumor Activity in NHL Xenografts and Is Well Tolerated in Non-Human Primates

Ann Maclaren, PhD BS, Nancy Levin, PhD, Henry Lowman, PhD, Mohit Trikha, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4105.
https://doi.org/10.1182/blood.V130.Suppl_1.4105.4105
Published: 2017
Journal Articles

Phase II Study Of Anti-CD19 Antibody Drug Conjugate (SAR3419) In Combination With Rituximab: Clinical Activity and Safety In Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (NCT01470456)

Bertrand Coiffier, MD, PhD, Catherine Thieblemont, MD, PhD, Sophie de Guibert, MD, Jehan Dupuis, MD, Vincent Ribrag, Réda Bouabdallah, MD, Franck Morschhauser, MD, PhD, Guillaume Cartron, MD, PhD, Steven Le Gouill, MD, PhD, Olivier Casasnovas, MD, Harald Holte, MD, PhD, Laurence Hatteville, Chiara Zilocchi, Corina Oprea, MD, Hervé Tilly, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 4395.
https://doi.org/10.1182/blood.V122.21.4395.4395
Published: 2013
Journal Articles

Targeting of CLEC12A In Acute Myeloid Leukemia by Antibody-Drug-Conjugates and Bispecific CLL-1×CD3 BiTE Antibody

Paul Noordhuis, PhD, Monique Terwijn, Arjo P Rutten, Linda Smit, PhD, Gert J. Ossenkoppele, MD, PhD, Gerrit J. Schuurhuis, PhD
Journal: Blood
Blood (2010) 116 (21): 2890.
https://doi.org/10.1182/blood.V116.21.2890.2890
Published: 2010
Journal Articles

Pharmacodynamic Effects of Administration of Maytansine Conjugated Anti-CD22 Monoclonal Antibodies to Cynomolgus Monkeys

Franklin Fuh, Reina Fuji, Kirsten A Poon, Dongwei Li, Clarissa David, Quyen Nguyen, Kathy Howell, Joseph Beyer, Paul Fielder, William Manning, Jr., Karen Berry, Vanitha Ramakrishnan, Andrew G. Polson, Allen Ebens, Saileta Prabhu, Marna Williams
Journal: Blood
Blood (2008) 112 (11): 4996.
https://doi.org/10.1182/blood.V112.11.4996.4996
Published: 2008
Journal Articles

Superior Anti-Tumor Activity of the CD19-Directed Immunotoxin, SAR3419 to Rituximab in Non-Hodgkin’s Xenograft Animal Models: Preclinical Evaluation.

Amro Aboukameel, MS, Anton-Scott Goustin, PhD, Ramzi Mohammad, PhD, Claudia Zuany-Amorim, PhD, Marie-Christine Bissery, PhD, Ayad M. Al-Katib, MD
Journal: Blood
Blood (2007) 110 (11): 2339.
https://doi.org/10.1182/blood.V110.11.2339.2339
Published: 2007
Journal Articles

An Open Label, Dose Escalation Study of AVE9633 Administered as a Single Agent by Intravenous (IV) Infusion Weekly for 2 Weeks in 4-Week Cycle to Patients with Relapsed or Refractory CD33-Positive Acute Myeloid Leukemia (AML).

Ollivier Legrand, MD, Maria B. Vidriales, MD, Xavier Thomas, MD, Charles Dumontet, MD, Anne Vekhoff, MD, Rodica Morariu-Zamfir, MD, John Lambert, MD, Jesus F. San Miguel, MD, Jean-Pierre Marie, MD
Journal: Blood
Blood (2007) 110 (11): 1850.
https://doi.org/10.1182/blood.V110.11.1850.1850
Published: 2007
Journal Articles

Anti-Myeloma Activity of the Maytansinoid Immunoconjugate of Internalizing Human Monoclonal Antibody Specific for HM1.24/BST2 (CD317).

Shuji Ozaki, Takafumi Tomura, Etsuko Sekimoto, Yoichi Tanaka, Kenichi Kitazoe, Jin Asano, Toshihiro Hashimoto, Masahiro Abe, Takayuki Furuta, Tomoyuki Tahara, Isao Ishida, Shiro Kataoka, Toshio Matsumoto
Journal: Blood
Blood (2005) 106 (11): 3388.
https://doi.org/10.1182/blood.V106.11.3388.3388
Published: 2005